Program Planning and Evaluation helps Cancer Center leadership chart the course of the Cancer Center, making it an integral part of meeting the Cancer Center's four primary objectives. Program Planning and Evaluation funds are used to support the Cancer Center's External Advisory Board, Program Retreats and Center Annual Retreats. The advisory boards and committees provide key input on all matters regarding research and management, including the development of new Cores, the strengthening of affiliations with other research institutions, and the facilitation of minority and community outreach efforts. Recent accomplishments of the External Advisory Board include providing recommendations to help increase institutional support, and completing reviews of Cores and protocol development processes and review and recommendations regarding the future affiliation with Lawrence Berkeley National Laboratory. By building partnerships that address the needs of communities in Northern California, the Community Advisory Board has recommended initiatives that challenge cancer care-related barriers and reduce cancer-related disparities. Cancer Center Annual Retreats help integrate the Cancer Center's community of investigators by providing forums for information sharing and idea exchange. Through the retreats, the Cancer Center has identified strengths, scientific areas that could be developed, and potential collaborations.
| Truillet, Charles; Parker, Matthew F L; Huynh, Loc T et al. (2018) Measuring glucocorticoid receptor expression in vivo with PET. Oncotarget 9:20399-20408 |
| Phillips, Kathryn A; Trosman, Julia R; Deverka, Patricia A et al. (2018) Insurance coverage for genomic tests. Science 360:278-279 |
| Phillips, Kathryn A (2018) Evolving Payer Coverage Policies on Genomic Sequencing Tests: Beginning of the End or End of the Beginning? JAMA 319:2379-2380 |
| Puri, Sapna; Roy, Nilotpal; Russ, Holger A et al. (2018) Replication confers ? cell immaturity. Nat Commun 9:485 |
| An, Zhenyi; Aksoy, Ozlem; Zheng, Tina et al. (2018) Epidermal growth factor receptor and EGFRvIII in glioblastoma: signaling pathways and targeted therapies. Oncogene 37:1561-1575 |
| Behr, Spencer C; Villanueva-Meyer, Javier E; Li, Yan et al. (2018) Targeting iron metabolism in high-grade glioma with 68Ga-citrate PET/MR. JCI Insight 3: |
| Rubenstein, James L; Geng, Huimin; Fraser, Eleanor J et al. (2018) Phase 1 investigation of lenalidomide/rituximab plus outcomes of lenalidomide maintenance in relapsed CNS lymphoma. Blood Adv 2:1595-1607 |
| An, Zhenyi; Knobbe-Thomsen, Christiane B; Wan, Xiaohua et al. (2018) EGFR Cooperates with EGFRvIII to Recruit Macrophages in Glioblastoma. Cancer Res 78:6785-6794 |
| Olshen, Adam; Wolf, Denise; Jones, Ella F et al. (2018) Features of MRI stromal enhancement with neoadjuvant chemotherapy: a subgroup analysis of the ACRIN 6657/I-SPY TRIAL. J Med Imaging (Bellingham) 5:011014 |
| Li, Megan; Kroetz, Deanna L (2018) Bevacizumab-induced hypertension: Clinical presentation and molecular understanding. Pharmacol Ther 182:152-160 |
Showing the most recent 10 out of 192 publications
